Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes. (Q51356877)

4 April 2018

title

Fructose-fed streptozotocin-injected rat: an alternative model for type 2 diabetes. (English)

1 reference

4 April 2018

0 references

Rachel D Wilson

1

1 reference

4 April 2018

Md Shahidul Islam

series ordinal

2

1 reference

4 April 2018

publication date

1 January 2012

1 reference

4 April 2018

published in

Pharmacological Reports

1 reference

4 April 2018

volume

64

1 reference

4 April 2018

issue

1

1 reference

4 April 2018

page(s)

129-139

1 reference

4 April 2018

Diagnosis and classification of diabetes mellitus

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Role of resistin in insulin sensitivity in rodents and humans

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Fructose, insulin resistance, and metabolic dyslipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Effects of treatment with St. John's Wort on blood glucose levels and pain perceptions of streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Abnormal Liver Function Test Predicts Type 2 Diabetes: A community-based prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Fructose loading induces cardiovascular and metabolic changes in nondiabetic and diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Fructose, weight gain, and the insulin resistance syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Lower serum creatinine is a new risk factor of type 2 diabetes: the Kansai healthcare study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Involvement of eotaxin, eosinophils, and pancreatic predisposition in development of type 1 diabetes mellitus in the BioBreeding rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Green tea extract decreases oxidative stress and improves insulin sensitivity in an animal model of insulin resistance, the fructose-fed rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Low serum creatinine is associated with type 2 diabetes in morbidly obese women and men: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Fructose-induced insulin resistance and hypertension in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Fasting blood glucose and diagnosis of type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Chinese cabbage (Brassica campestris L.) does not improve glucose tolerance, serum insulin, or blood lipid profiles in a rat model of type-2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Nongenetic model of type 2 diabetes: a comparative study.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Experimental rodent models of type 2 diabetes: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Protective effect of diltiazem hydrochloride on the occurrence of alloxan- or streptozotocin-induced diabetes in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

The effect of low versus high dose of streptozotocin in cynomolgus monkeys (Macaca fascilularis).

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Determination of glycogen in small tissue samples

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Establishment and pathophysiological characterization of type 2 diabetic mouse model produced by streptozotocin and nicotinamide.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

New agents for Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Increased sorbitol pathway activity generates oxidative stress in tissue sites for diabetic complications

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Lipoprotein (a) in type 2 diabetes mellitus: Relation to LDL:HDL ratio and glycemic control

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Insulin sensitivity and insulin secretion determined by homeostasis model assessment and risk of diabetes in a multiethnic cohort of women: the Women's Health Initiative Observational Study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Adaptation of Sprague Dawley rats to long-term feeding of high fat or high fructose diets.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Metabolic effects of fructose and the worldwide increase in obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

Adipose tissue-derived factors: impact on health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970739-9

7 January 2021

10.1016/S1734-1140(12)70739-9

Identifiers

DOI

1 reference

4 April 2018

PubMed ID

22580529

1 reference

4 April 2018